BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29194934)

  • 1. Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis.
    Cacciola I; Filomia R; Alibrandi A; Franzè MS; Caccamo G; Maimone S; Saitta C; Saffioti F; Squadrito G; Raimondo G
    Liver Int; 2018 Jul; 38(7):1220-1229. PubMed ID: 29194934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher free serum cortisol is associated with worse survival in acute variceal bleeding because of cirrhosis: a prospective study.
    Triantos CK; Kalafateli M; Samonakis D; Zisimopoulos K; Papiamonis N; Sapountzis A; Michalaki M; Theocharis G; Thomopoulos K; Labropoulou-Karatza C; Kyriazopoulou V; Jelastopulu E; Kouroumalis EA; Nikolopoulou V; Burroughs AK
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1125-32. PubMed ID: 25089543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
    Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
    Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance.
    Franzè MS; Filomia R; Caccamo G; Pitrone C; Alibrandi A; Saitta C; Caspanello AR; Asero C; Arcadi V; Raimondo G; Cacciola I
    J Pers Med; 2022 Oct; 12(11):. PubMed ID: 36579534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild hyperbilirubinemia as a marker of oesophageal varices in HCV-related compensated cirrhotic patients.
    Mikuła T; Suchacz MM; Stańczak W; Jabłońska J; Kozłowska J; Cybula A; Cianciara J; Wiercińska-Drapało A
    Pol Merkur Lekarski; 2019 May; 46(275):209-212. PubMed ID: 31152532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients.
    Giannini EG; Savarino V; Farinati F; Ciccarese F; Rapaccini G; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
    Liver Int; 2013 Nov; 33(10):1594-600. PubMed ID: 23654354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.
    Giannini EG; Risso D; Testa R; Trevisani F; Di Nolfo MA; Del Poggio P; Benvegnù L; Ludovico Rapaccini G; Farinati F; Zoli M; Borzio F; Caturelli E;
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1378-84. PubMed ID: 17059899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study.
    Lampertico P; Invernizzi F; Viganò M; Loglio A; Mangia G; Facchetti F; Primignani M; Jovani M; Iavarone M; Fraquelli M; Casazza G; de Franchis R; Colombo M
    J Hepatol; 2015 Nov; 63(5):1118-25. PubMed ID: 26100495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma.
    Chang CY; Hsieh WY; Chau GY; Chen PH; Su CW; Hou MC; Lei HJ; Huo TI; Huang YH; Lin HC; Wu JC
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1368-1377. PubMed ID: 29994873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis.
    Pacella CM; Francica G; Di Lascio FM; Arienti V; Antico E; Caspani B; Magnolfi F; Megna AS; Pretolani S; Regine R; Sponza M; Stasi R
    J Clin Oncol; 2009 Jun; 27(16):2615-21. PubMed ID: 19332729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis.
    Nagasue N; Kohno H; Tachibana M; Yamanoi A; Ohmori H; El-Assal ON
    Ann Surg; 1999 Jan; 229(1):84-90. PubMed ID: 9923804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis.
    Ripoll C; Bari K; Garcia-Tsao G
    J Clin Gastroenterol; 2015 Aug; 49(7):613-9. PubMed ID: 25203362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
    Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
    Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
    Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S
    Oncology; 2013; 84(1):32-8. PubMed ID: 23076239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.